Research and development
For nearly 30 years, research and development of innovative pharmaceutical products has formed the heart of Orexo. A diverse and inclusive team of experts work continuously to improve existing treatments and develop new products, based on proprietary drug-delivery technologies, for patients worldwide.
AmorphOX® is a world-class powder technology for innovative drug delivery
With the introduction of Orexo’s latest drug-delivery technology, AmorphOX, we are meeting the challenges of delivering large and small molecules previously thought to be impossible to formulate for alternative routes of administration.
Improved handling and storage under accelerated conditions
Stability data, where small molecules, peptides, and biologics, are tested together with Orexo´s AmorphOX powder-technology demonstrates both physical and chemical stability - enabling improved handling and shelf life.
Clinical data shows strong pharmacokinetic data
Multiple clinical trials have demonstrated qualities such as rapid absorption and excellent bioavailability.
AmorphOX is the backbone of next-generation pharmaceuticals
The AmorphOX technology can be applied to a broad scope of active ingredients, including small and large molecules. It is already being used across multiple research projects, including those at an early stage and rescue medications at a clinical stage. For projects that goes beyond Orexo´s key therapeutic area opioid dependence and adjacent diseases and conditions the company is seeking partnerships for development and commercialization.
Partner with us
Talk to our Business Development team to explore projects of interest and discover how AmorphOX could be applied to your APIs.
